Holding(s) in Company

RNS Number : 1173E

Microgen PLC

13 July 2016

 

For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				Microgen  PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		Kestrel Partners LLP
4. Full name of shareholder(s)  (if different from 3.):iv		Kestrel Opportunities, a cell of Guernsey Portfolios PCC Ltd (through BNY Mellon Nominees Limited) and various other clients of Kestrel Partners LLP (through Bank of New York Nominees Limited)
5. Date of the transaction and date on which the threshold is crossed or reached: v		11 July 2016
6. Date on which issuer notified:		13 July 2016
7. Threshold(s) that is/are crossed or reached: vi, vii		6%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares of 6 3/7p each ISIN  GB00BVVHWX30

3,525,024

3,525,024

n/a

n/a

3,655,024

n/a

6.19%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

n/a

n/a

n/a

n/a

n/a

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

n/a

n/a

n/a

n/a

n/a

Nominal

Delta

n/a

n/a

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,655,024

6.19%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Indirect - BNY Mellon Nominees Limited -  2,928,521 Shares. 4.96% of voting rights Indirect - Bank of New York Nominees Limited -    726,503 Shares. 1.23% of voting rights
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Disclosure based on Total voting rights of  59,080,188 The indirect voting rights held under (9) relate to shares held in client portfolios managed by Kestrel Partners LLP under discretionary investment management agreements
14. Contact name:	Ian Forrest
15. Contact telephone number:	0203 371 6100

 

END

 

 

HOLSFFFIDFMSEEW